We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+0.25%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$119B
AUM Growth
+$5.64B
(+5%)
Cap. Flow
+$6.41B
Cap. Flow
% of AUM
5.41%
Top 10 Holdings %
Top 10 Hldgs %
16.36%
Holding
4,406
New
331
Increased
2,055
Reduced
1,449
Closed
309
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.02B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$944M |
| 3 |
AT&T
T
|
+$753M |
| 4 |
Vanguard Extended Market ETF
VXF
|
+$553M |
| 5 |
Linde
LIN
|
+$379M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APC
Anadarko Petroleum
APC
|
+$331M |
| 2 |
FDC
First Data Corporation
FDC
|
+$331M |
| 3 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$312M |
| 4 |
Blackstone
BX
|
+$277M |
| 5 |
FirstEnergy
FE
|
+$261M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.59% |
| 2 | Technology | 10.75% |
| 3 | Financials | 9.31% |
| 4 | Consumer Discretionary | 6.45% |
| 5 | Communication Services | 5.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PDLI
3751
DELISTED
PDL BioPharma, Inc.
PDLI
| $185K | ﹤0.01% |
85,646
-20,635
| -19% | -$55.2K |
|
3752
McEwen Inc
MUX
$1.03B
| $183K | ﹤0.01% |
11,746
-6,976
| -37% | -$127K |
|
|
BMTX
3753
DELISTED
BM Technologies, Inc.
BMTX
| $183K | ﹤0.01% |
+18,050
| New | +$183K |
|
|
CURO
3754
DELISTED
CURO Group Holdings Corp.
CURO
| $182K | ﹤0.01% |
+13,753
| New | +$176K |
|
|
LTS
3755
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
| $181K | ﹤0.01% |
76,344
+7,441
| +11% | +$19.4K |
|
|
GHL
3756
DELISTED
Greenhill & Co., Inc.
GHL
| $180K | ﹤0.01% |
13,690
+1,783
| +15% | +$25.5K |
|
3757
MasterCraft Boat Holdings
MCFT
$579M
| $178K | ﹤0.01% |
11,957
-3,225
| -21% | -$52.6K |
|
|
PRTY
3758
DELISTED
Party City Holdco Inc.
PRTY
| $178K | ﹤0.01% |
31,137
-29,864
| -49% | -$170K |
|
|
DERM
3759
CALL
DELISTED
Dermira, Inc.
DERM
| $178K | ﹤0.01% |
+27,800
| New | +$232K |
|
3760
Lifecore Biomedical
LFCR
$166M
| $177K | ﹤0.01% |
16,344
-2,171
| -12% | -$23.6K |
|
3761
Five Point Holdings
FPH
$373M
| $175K | ﹤0.01% |
23,365
-40
| -0.2% | -$296 |
|
|
EXPR
3762
DELISTED
Express, Inc.
EXPR
| $175K | ﹤0.01% |
2,547
-2,528
| -50% | -$124K |
|
3763
Amneal Pharmaceuticals
AMRX
$5.85B
| $174K | ﹤0.01% |
59,750
-38,328
| -39% | -$134K |
|
3764
Inovio Pharmaceuticals
INO
$55.7M
| $174K | ﹤0.01% |
7,053
+1,877
| +36% | +$57.1K |
|
3765
NexGen Energy
NXE
$6.06B
| $174K | ﹤0.01% |
134,331
+5,789
| +5% | +$7.97K |
|
3766
Vera Bradley
VRA
$97M
| $173K | ﹤0.01% |
17,107
+5,055
| +42% | +$53.5K |
|
3767
Lands' End
LE
$370M
| $172K | ﹤0.01% |
15,109
-5,432
| -26% | -$57.3K |
|
|
ACOR
3768
DELISTED
Acorda Therapeutics
ACOR
| $172K | ﹤0.01% |
501
-7
| -1% | -$3.81K |
|
|
FRTA
3769
DELISTED
Forterra, Inc
FRTA
| $172K | ﹤0.01% |
+23,892
| New | +$154K |
|
3770
Accuray
ARAY
$32M
| $171K | ﹤0.01% |
62,008
+4,619
| +8% | +$15.3K |
|
|
RUBY
3771
DELISTED
Rubius Therapeutics, Inc
RUBY
| $171K | ﹤0.01% |
21,818
+4,690
| +27% | +$54.7K |
|
|
XRN
3772
Chiron Real Estate Inc
XRN
$514M
| $170K | ﹤0.01% |
2,992
+964
| +48% | +$52K |
|
3773
TETRA Technologies
TTI
$1.14B
| $170K | ﹤0.01% |
84,499
+5,216
| +7% | +$8.95K |
|
|
ICOL
3774
DELISTED
iShares MSCI Colombia ETF
ICOL
| $169K | ﹤0.01% |
13,300
| – | – |
|
|
TLRD
3775
DELISTED
Tailored Brands, Inc.
TLRD
| $169K | ﹤0.01% |
38,306
-69,122
| -64% | -$350K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q3 2019 Portfolio in Review
As of Q3 2019, Credit Suisse held 4,406 positions worth $119B, up 5% from $113B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Credit Suisse deployed $6.41B of net new capital in Q3 2019, opening 331 new positions and adding to 2,055 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Genesee & Wyoming Inc., an estimated $312M trimmed.
- Credit Suisse's largest Q3 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
- Credit Suisse added most to Allergan plc in Q3 2019, an estimated $1.02B increase.
- Credit Suisse's biggest Q3 2019 reduction was Genesee & Wyoming Inc., cutting an estimated $312M.
- Credit Suisse fully exited Anadarko Petroleum in Q3 2019, selling an estimated $331M.
- Credit Suisse's ten largest holdings make up 16% of its $119B portfolio in Q3 2019.
- Credit Suisse opened 331 new positions and closed 309 in Q3 2019.
- Credit Suisse's portfolio value rose 5% quarter-over-quarter to $119B.
Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.